|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03138837 |
|
Date of registration:
|
01/05/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage
|
|
Scientific title:
|
Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage. Potential Role of the Apparent Diffusion Coefficient (ADC) Value |
|
Date of first enrolment:
|
May 15, 2017 |
|
Target sample size:
|
385 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03138837 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Abdelwahab R. Hashem, Msc |
|
Address:
|
|
|
Telephone:
|
01069678979 |
|
Email:
|
abdelwahab_hashem@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Ahmed Elassmy, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Urology and Nephrology center |
|
|
Name:
|
Abdelwahab R. Hashem, Msc |
|
Address:
|
|
|
Telephone:
|
00201069678979 |
|
Email:
|
abdelwahab_hashem@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Khaled Sheir, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Urology and Nephrology center |
|
|
Name:
|
Mohamed AboElghar, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Urology and Nephrology center |
|
|
Name:
|
Hassan Abol-Enein, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Urology and Nephrology center |
|
|
Name:
|
Ahmed O. Mosbah, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Urology and Nephrology center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Men and women 18 years or older
- Suspected by the out-patient flexible cystoscopy as Non-muscle invasive bladder
cancer.
- Patient who will undergo radical cystectomy.
- Patient with history of allergy to iodinated contrast media
Exclusion Criteria:
- Refuse to complete study requirements
- Patient with any of the following:
1. Any metallic fragment or foreign body
2. Coronary and peripheral artery stents
3. Aortic stent graft
4. Prosthetic heart valves and annuloplasty rings
5. Cardiac pacemaker
6. Implanted cardioverter-defibrillator (ICD)
7. Retained trans venous pacemaker and defibrillator leads
8. Cochlear, otologic, or other ear implant
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Bladder Cancer
|
|
Diagnoses Disease
|
|
Magnetic Resonance Imaging
|
|
Apparent Diffusion Coefficient
|
|
Intervention(s)
|
|
Diagnostic Test: Magnetic resonance imaging
|
|
Primary Outcome(s)
|
|
assess the diagnostic performance of 3-T DW-MRI in detecting and staging bladder cancer
[Time Frame: 1 year]
|
|
Secondary ID(s)
|
|
R/17.02.31
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|